Summary:
Click image to enlarge
The Seabreeze study is testing an investigational medication called Rademikibart to see if it can help stop or reduce asthma or COPD symptoms from coming back or getting worse after a flare-up.
Qualified Participants Must:
• Have asthma or COPD diagnosed by a doctor
•
Be on regular treatment for their condition
•
Meet basic age and health requirements
Qualified Participants May Receive:
Qualified participants will receive study medication and study-related care at no cost, and may receive payment for time and travel.